What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Retina
Frank G. Holz mostly deals with Macular degeneration, Ophthalmology, Visual acuity, Fluorescein angiography and Pathology.
His Macular degeneration research is multidisciplinary, incorporating perspectives in Retinal pigment epithelium, Lipofuscin, Retinopathy, Age related and Atrophy.
His Ophthalmology research is multidisciplinary, incorporating elements of Retina and Ranibizumab.
His studies in Visual acuity integrate themes in fields like Diabetic retinopathy, Randomized controlled trial, Aflibercept and Clinical trial.
Frank G. Holz focuses mostly in the field of Fluorescein angiography, narrowing it down to topics relating to Optical coherence tomography and, in certain cases, Outer nuclear layer.
His Pathology research includes themes of Choroidal neovascularization, Angioid streaks and Macular disease.
His most cited work include:
- A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants (638 citations)
- Seven new loci associated with age-related macular degeneration (584 citations)
- Intravitreal aflibercept for diabetic macular edema. (441 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Ophthalmology, Macular degeneration, Retinal, Visual acuity and Pathology.
His work on Fluorescein angiography, Optical coherence tomography, Retinal pigment epithelium and Choroidal neovascularization as part of general Ophthalmology study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His biological study spans a wide range of topics, including Ophthalmoscopy and Angiography.
Frank G. Holz has included themes like Prospective cohort study, Age related and Atrophy in his Macular degeneration study.
His Retinal study combines topics from a wide range of disciplines, such as Retinopathy, Retina and Autofluorescence.
His work carried out in the field of Visual acuity brings together such families of science as Diabetic retinopathy, Optometry and Ranibizumab.
He most often published in these fields:
- Ophthalmology (50.81%)
- Macular degeneration (34.85%)
- Retinal (21.52%)
What were the highlights of his more recent work (between 2017-2021)?
- Ophthalmology (50.81%)
- Macular degeneration (34.85%)
- Retinal (21.52%)
In recent papers he was focusing on the following fields of study:
Frank G. Holz mainly focuses on Ophthalmology, Macular degeneration, Retinal, Visual acuity and Age related.
Prospective cohort study is closely connected to Aflibercept in his research, which is encompassed under the umbrella topic of Ophthalmology.
His Macular degeneration study combines topics in areas such as Retinal pigment epithelium, Clinical trial and Atrophy.
His Retinal research incorporates themes from Retina and Autofluorescence.
His study looks at the relationship between Visual acuity and fields such as Adverse effect, as well as how they intersect with chemical problems.
He combines subjects such as Multimodal imaging and MEDLINE with his study of Age related.
Between 2017 and 2021, his most popular works were:
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration (147 citations)
- Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials. (108 citations)
- Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group (68 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
His primary areas of investigation include Ophthalmology, Macular degeneration, Visual acuity, Retinal and Optical coherence tomography.
His study in Mesopic vision, Retinal pigment epithelium, Fundus, Microperimetry and Choroidal neovascularization is done as part of Ophthalmology.
The study incorporates disciplines such as Choroid, Prospective cohort study, Age related and Atrophy in addition to Macular degeneration.
His Visual acuity research is multidisciplinary, relying on both Tolerability, Adverse effect, Randomized controlled trial and Aflibercept.
He interconnects Signal void, Melanin, Retina and Tomography in the investigation of issues within Retinal.
The Optical coherence tomography study combines topics in areas such as Autofluorescence and Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
